BlackRock
ZBH icon

BlackRock’s Zimmer Biomet ZBH Stock Holding History

BlackRock’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-125,660
Closed -$14.6M – 5189
2020
Q2 		$14.6M Buy
+125,660
New +$14.5M ﹤0.01% 2973

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock's ZBH Position: Q2 2026 in Review

BlackRock increased its Zimmer Biomet (ZBH) stake by 1.8% in Q2 2026, buying an estimated $24M and bringing the position to 15,614,847 shares worth $1.34B. The position accounts for 0.02% of the portfolio, ranked #606.

BlackRock first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.37B in Q2 2021. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • BlackRock held 15,614,847 shares of Zimmer Biomet worth $1.34B as of Q2 2026.
  • BlackRock bought 274,041 Zimmer Biomet shares in Q2 2026, an estimated $24M.
  • Zimmer Biomet made up 0.02% of BlackRock's portfolio in Q2 2026, its #606 holding.
  • BlackRock first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • BlackRock's Zimmer Biomet position peaked at $3.37B in Q2 2021.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.